Good D, Busfield F, Duffy D, Lovelock P K, Kesting J B, Cameron D P, Shaw J T
Department of Diabetes and Endocrinology, Princess Alexandra Hospital, Brisbane, Australia.
J Bone Miner Res. 2001 Jan;16(1):33-8. doi: 10.1359/jbmr.2001.16.1.33.
Paget's disease of bone is a common condition characterized by bone pain, deformity, pathological fracture, and an increased incidence of osteosarcoma. Genetic factors play a role in the pathogenesis of Paget's disease but the molecular basis remains largely unknown. Susceptibility loci for Paget's disease of bone have been mapped to chromosome 6p21.3 (PDB1) and 18q21.1-q22 (PDB2) in different pedigrees. We have identified a large pedigree of over 250 individuals with 49 informative individuals affected with Paget's disease of bone; 31 of whom are available for genotypic analysis. The disease is inherited as an autosomal dominant trait in the pedigree with high penetrance by the sixth decade. Linkage analysis has been performed with markers at PDB1; these data show significant exclusion of linkage with log10 of the odds ratio (LOD) scores < -2 in this region. Linkage analysis of microsatellite markers from the PDB2 region has excluded linkage with this region, with a 30 cM exclusion region (LOD score < -2.0) centered on D18S42. These data confirm the genetic heterogeneity of Paget's disease of bone. Our hypothesis is that a novel susceptibility gene relevant to the pathogenesis of Paget's disease of bone lies elsewhere in the genome in the affected members of this pedigree and will be identified using a microsatellite genomewide scan followed by positional cloning.
骨佩吉特病是一种常见病症,其特征为骨痛、畸形、病理性骨折以及骨肉瘤发病率增加。遗传因素在骨佩吉特病的发病机制中起作用,但分子基础仍 largely 未知。在不同家系中,骨佩吉特病的易感基因座已被定位到6号染色体p21.3(PDB1)和18号染色体q21.1 - q22(PDB2)。我们鉴定出一个超过250人的大家系,其中49名有信息的个体患有骨佩吉特病;其中31人可用于基因分型分析。该疾病在这个家系中作为常染色体显性性状遗传,到第六个十年时具有高外显率。已使用PDB1处的标记进行连锁分析;这些数据显示在该区域与对数优势比(LOD)分数< -2存在显著的连锁排除。来自PDB2区域的微卫星标记的连锁分析已排除与该区域的连锁,以D18S42为中心有一个30 cM的排除区域(LOD分数< -2.0)。这些数据证实了骨佩吉特病的遗传异质性。我们的假设是,与骨佩吉特病发病机制相关的一个新的易感基因位于这个家系受影响成员基因组的其他位置,并将通过全基因组微卫星扫描随后进行定位克隆来鉴定。